• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Management of Buerger's Disease in Endovascular Era.血管腔内治疗时代的血栓闭塞性脉管炎管理
Int J Angiol. 2019 Sep;28(3):173-181. doi: 10.1055/s-0039-1685200. Epub 2019 Apr 19.
2
The Efficacy of Percutaneous Transluminal Angioplasty on the Limb Salvage and Recovery of Symptoms in Patients With Buerger's Disease With Critical Limb Ischemia.经皮腔内血管成形术对伴有临界肢体缺血的伯格氏病患者的肢体保全和症状恢复的疗效。
J Invasive Cardiol. 2020 Jun;32(6):E158-E167. doi: 10.25270/jic/20.00058.
3
Endovascular Treatment of Thromboangiitis Obliterans (Buerger's Disease).血栓闭塞性脉管炎(伯格氏病)的血管内治疗
Vasc Endovascular Surg. 2018 Feb;52(2):124-130. doi: 10.1177/1538574417744085. Epub 2017 Dec 13.
4
Clinical outcomes of extended endovascular recanalization of 16 consecutive Buerger's disease patients.16例连续性血栓闭塞性脉管炎患者血管腔内延长再通术的临床结果
Vascular. 2019 Jun;27(3):233-241. doi: 10.1177/1708538118805623. Epub 2018 Oct 10.
5
Endovascular Recanalization of Thromboangiitis Obliterans (Buerger's Disease) in Twenty-Eight Consecutive Patients and Combined Antegrade-Retrograde Intervention in Eight Patients.28 例血栓闭塞性脉管炎(伯格氏病)患者的血管内再通治疗及 8 例患者联合顺行-逆行介入治疗。
Cardiovasc Intervent Radiol. 2019 Jun;42(6):820-828. doi: 10.1007/s00270-019-02193-x. Epub 2019 Mar 4.
6
Short-term efficacy of endovascular procedures for lower extremity thromboangiitis obliterans (Buerger's disease).下肢血栓闭塞性脉管炎(伯格氏病)血管内介入治疗的短期疗效。
Postgrad Med. 2024 Jun;136(5):577-583. doi: 10.1080/00325481.2024.2373678. Epub 2024 Jun 28.
7
Efficacy of Transpedal Retrograde Approach in Endovascular Treatment of Patients With Buerger's Disease.经皮逆行入路在布加氏病腔内治疗中的疗效。
J Invasive Cardiol. 2023 Feb;36(2):E84-E91. doi: 10.25270/jic/22.00207. Epub 2022 Dec 22.
8
Endovascular Revascularization for the Obstruction after Patch Angioplasty in Buerger's Disease.血栓闭塞性脉管炎补片血管成形术后阻塞的血管内血运重建术
Korean J Thorac Cardiovasc Surg. 2014 Apr;47(2):174-7. doi: 10.5090/kjtcs.2014.47.2.174. Epub 2014 Apr 10.
9
Vascular reconstruction in Buerger's disease: is it feasible?
Surg Today. 2002;32(12):1042-7. doi: 10.1007/s005950200211.
10
Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.通过自体骨髓单个核细胞移植对重症肢体缺血的血栓闭塞性脉管炎(伯格氏病)患者进行治疗性血管生成。
J Vasc Surg. 2008 Dec;48(6 Suppl):53S-60S; discussion 60S. doi: 10.1016/j.jvs.2008.09.005.

引用本文的文献

1
Successful lumbal sympathetic block as an alternative therapy for improving Buerger's disease: A rare case report and literature review.成功实施腰交感神经阻滞作为改善血栓闭塞性脉管炎的替代疗法:1例罕见病例报告及文献综述
Int J Surg Case Rep. 2023 Sep;110:108778. doi: 10.1016/j.ijscr.2023.108778. Epub 2023 Sep 1.
2
The use of "off the shelf" percutaneous deep venous arterialization technology for a patient with severe chronic limb ischemia with no other options for limb salvage.将“现成的”经皮深静脉动脉化技术用于一名患有严重慢性肢体缺血且没有其他肢体挽救选择的患者。
J Vasc Surg Cases Innov Tech. 2023 May 16;9(3):101212. doi: 10.1016/j.jvscit.2023.101212. eCollection 2023 Sep.
3
Endovascular treatment of Buerger's disease in patients with critical limb ischaemia.腔内治疗肢体缺血性重症患者的伯格氏病。
Cardiovasc J Afr. 2022;33(5):254-259. doi: 10.5830/CVJA-2022-018. Epub 2022 Jun 30.
4
A Rare Case of Buerger's Disease Successfully Treated by Rotarex Mechanical Thrombectomy in Bilateral Lower Extremities.Rotarex机械血栓切除术成功治疗双下肢血栓闭塞性脉管炎1例罕见病例
Acta Cardiol Sin. 2021 Nov;37(6):657-660. doi: 10.6515/ACS.202111_37(6).20210628B.
5
Integrated analysis of long non-coding RNA-microRNA-mRNA competing endogenous RNAregulatory networks in thromboangiitis obliterans.血栓闭塞性脉管炎中长非编码 RNA- microRNA-mRNA 竞争内源性 RNA 调控网络的综合分析。
Bioengineered. 2021 Dec;12(2):12023-12037. doi: 10.1080/21655979.2021.2002497.
6
The Imbalance among Oxidative Biomarkers and Antioxidant Defense Systems in Thromboangiitis Obliterans (Winiwarter-Buerger Disease).血栓闭塞性脉管炎(温尼瓦特-伯格病)中氧化生物标志物与抗氧化防御系统之间的失衡
J Clin Med. 2020 Apr 7;9(4):1036. doi: 10.3390/jcm9041036.

本文引用的文献

1
How to Treat a Patient with Thromboangiitis Obliterans: A Systematic Review.如何治疗血栓闭塞性脉管炎患者:一项系统评价
Ann Vasc Surg. 2018 May;49:219-228. doi: 10.1016/j.avsg.2017.10.022. Epub 2018 Feb 5.
2
Immediate and late outcomes of endovascular therapy for lower extremity arteries in Buerger disease.布加氏病下肢动脉腔内治疗的即刻和远期疗效。
J Vasc Surg. 2018 Jun;67(6):1769-1777. doi: 10.1016/j.jvs.2017.09.020. Epub 2017 Nov 20.
3
Buerger's disease: providing integrated care.血栓闭塞性脉管炎:提供综合护理。
J Multidiscip Healthc. 2016 Oct 12;9:511-518. doi: 10.2147/JMDH.S109985. eCollection 2016.
4
Endovascular Treatment of Multilevel Chronic Total Occlusion Using a Stent Puncture Technique in Buerger's Disease.采用支架穿刺技术对布加综合征多节段慢性完全闭塞病变进行血管内治疗
Korean Circ J. 2016 May;46(3):417-20. doi: 10.4070/kcj.2016.46.3.417. Epub 2016 Apr 26.
5
Percutaneous Transluminal Angioplasty in Patients With Infrapopliteal Arterial Disease: Systematic Review and Meta-Analysis.经皮腔内血管成形术治疗下肢动脉疾病患者:系统评价和荟萃分析。
Circ Cardiovasc Interv. 2016 May;9(5):e003468. doi: 10.1161/CIRCINTERVENTIONS.115.003468.
6
Increased Serum HMGB-1, ICAM-1 and Metalloproteinase-9 Levels in Buerger's Patients.
Curr Vasc Pharmacol. 2016;14(4):382-7. doi: 10.2174/1570161114666160303111355.
7
Mechanisms of thrombosis, available treatments and management challenges presented by thromboangiitis obliterans.血栓闭塞性脉管炎的血栓形成机制、现有治疗方法及管理挑战。
Curr Med Chem. 2015;22(16):1992-2001. doi: 10.2174/0929867322666150429112111.
8
Endarteritis obliterans in the pathogenesis of Buerger's disease from the pathological and immunohistochemical points of view.从病理和免疫组化角度看血栓闭塞性脉管炎中闭塞性动脉内膜炎在伯格氏病发病机制中的作用
Circ J. 2014;78(12):2819-26. doi: 10.1253/circj.cj-14-0656. Epub 2014 Oct 8.
9
Outcomes following infrapopliteal angioplasty for critical limb ischemia.下肢动脉腔内成形术治疗严重肢体缺血的结果。
J Vasc Surg. 2013 Jun;57(6):1455-63; discussion 1463-4. doi: 10.1016/j.jvs.2012.10.109. Epub 2013 Feb 1.
10
The ongoing battle between infrapopliteal angioplasty and bypass surgery for critical limb ischemia.在治疗严重肢体缺血方面,腘动脉以下血管成形术与旁路手术之间的持续较量。
Ann Vasc Surg. 2012 Nov;26(8):1145-53. doi: 10.1016/j.avsg.2012.02.006. Epub 2012 Jul 25.

血管腔内治疗时代的血栓闭塞性脉管炎管理

Management of Buerger's Disease in Endovascular Era.

作者信息

Ghoneim Baker M, Karmota Ahmed G, Abuhadema Ahmed M, Shaker Ahmed A, Abdelmawla Hany M, Nasser Mahmoud M, Elmahdy Hossam Y, Mostafa Hesham A, Khairy Hussein M

机构信息

Vascular Surgery Department, Faculty of Medicine, Cairo University, Egypt.

出版信息

Int J Angiol. 2019 Sep;28(3):173-181. doi: 10.1055/s-0039-1685200. Epub 2019 Apr 19.

DOI:10.1055/s-0039-1685200
PMID:31452585
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6707802/
Abstract

This study was aimed to report data on the feasibility, safety, and effectiveness of endovascular procedures in a thromboangiitis obliterans diagnosed patients presenting with critical limb ischemia (CLI). Prospective study conducted on patients affected by Buerger's disease who presented to our center along 2 years. Clinical, radiological, and patient-based outcomes were recorded at 3, 6, and 12 months after the intervention. Total 39 patients were included in the study. Fifteen (38.5%) patients underwent percutaneous transluminal angioplasty, another 15 patients (38.5%) underwent follow-up on medical treatment, there are four other patients (10.3%) underwent surgical bypass, and five (12.8%) patients underwent lumbar sympathectomy. The 12 months' outcome showed 66.7% technical success in endovascular group with 46.7% patency rate ( -value = 0.06), 86.7% limb salvage rate (LSR; -value < 0.04), and 66.7% clinical improvement ( -value = 0.005). The endovascular management of Buerger's disease is feasible, save, and effective with high rate of LSR and clinical improvement.

摘要

本研究旨在报告血管内介入治疗在诊断为血栓闭塞性脉管炎且伴有严重肢体缺血(CLI)患者中的可行性、安全性及有效性。对两年来就诊于本中心的血栓闭塞性脉管炎患者进行前瞻性研究。在干预后3个月、6个月和12个月记录临床、影像学及基于患者的结局。本研究共纳入39例患者。15例(38.5%)患者接受了经皮腔内血管成形术,另外15例(38.5%)患者接受药物治疗随访,另有4例(10.3%)患者接受了外科旁路手术,5例(12.8%)患者接受了腰交感神经切除术。12个月的结局显示血管内治疗组技术成功率为66.7%,通畅率为46.7%(P值=0.06),肢体挽救率(LSR)为86.7%(P值<0.04),临床改善率为66.7%(P值=0.005)。血栓闭塞性脉管炎的血管内治疗可行、安全且有效,具有较高的肢体挽救率和临床改善率。